Hide Board Information

Show Board Information

GRANITE MASTER ISSUER CLS`6A1`5.6% BDS 24/12/54 GBP100000 83DA

Board Mod: Add me as mod

Asst Mods:

Last Post: 06/04/2012 2:03:26 AM

Board Marks: 0

Posts Today: 0

Board Views Today: 3

GRANITE MASTER ISSUER CLS`6A1`5.6% BDS 24/12/54 GBP100000 (83DA) Stock Message Board

Find 83DA Recent News, 83DA Filings, 83DA Stock Quote, 83DA Stock Chart, 83DA Research & Opinions Below

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

Be the first to post on GRANITE MASTER ISSUER CLS`6A1`5.6% BDS 24/12/54 GBP100000 83DA

Recent Articles

• Lleida.net Reports Significant EBITDA Growth of 33% in 2025
• BW Energy Enters New Chapter with Deepsea Mira Drilling Contract
• Howard Lutnick Discusses Upcoming Chip Import Probe Results
• Lleida.net Achieves Remarkable 33% Growth in Q2 2025 EBITDA
• RESVION Expands Its Portfolio with Tremonia Mobility Acquisition
• SCO Summit in China: Cultivating Unity and Collaboration
• FORVIA H1 2025: Insights on Growth and Strategic Changes
• Roche Advances Alzheimer’s Innovations with Groundbreaking Data
• Innovative Collaboration Between EnduroSat and WISeSat.Space
• Heineken N.V. Achieves Strong Growth in Half-Year Results
• Heineken Holding N.V. Shows Robust Growth in Half-Year Results
• BW Energy Expands Operations with Deepsea Mira Contract
• Bitcoin's Astounding Growth: Chamath's 2013 Call Wins Big
• Heineken N.V. Achieves Strong Half-Year Results for 2025
• FORVIA Reports Strong Half-Year Results and Confirms Guidance
• Heineken Holding N.V. Shows Commitment with Strong Half-Year Performance
• Ambassador Linda Thomas-Greenfield Joins Rendeavour's Vision
• Kalaam Telecom and SecurityHQ Join Forces for Cybersecurity Growth
• Steve Eisman's Take on Opendoor's Soaring Stock Price
• Akeso's Ivonescimab Receives NMPA Approval for Lung Cancer Treatment
• Revolutionizing Pet Eye Care: Dômes Pharma and Fear Free Unite
• Samsung's Bold $16.5 Billion Chip Deal to Compete in Tech Sector
• Exploring the Success of CBD Fair Guangzhou's 2025 Edition
• Economic Impact of Trump's Trade Deal: What Comes Next?
• Antengene Prepares for Major Presentation on ATG-022 at ESMO
• How Japan's $550 Billion Deal Can Boost TSMC's Growth in the US
• Hengrui Pharma and GSK Forge Agreement for Advanced Drug Development
• Time Is Running Out for Solar Tax Credit Savings with All Energy Solar
• US and China Seek Trade Solutions Amid Tariff Tensions
• Introducing Automate's Push PRO: Revolutionary Shade Control
• Exciting Esports World Cup Promotion from JBO Thailand
• Harbour BioMed Unveils Strong Profit Predictions for Future Growth
• Ascletis Begins Significant Obesity Study with ASC30 Drug
• Elpis Biopharmaceuticals Partners with NCCS for Groundbreaking Research
• Perseus Mining's Operational Highlights and Financial Overview
• Shara Magomedov Shines at UFC Night with Epic Victory
• Investors Urged to Participate in Class Action Against Centene
• Exploring America’s Hidden Resource Potential and Technology
• Trump's New Tariff Deal with EU: Impacts and Insights
• Shaquille O'Neal's Hilarious Showdown with Jimmy Kimmel
• Empowering Hims & Hers Health Shareholders: Your Legal Guide
• Public Sentiment on Trump's Tax Cuts: A Closer Look
• Innovative Cooling Solutions Pioneered by i2Cool for a Sustainable Future
• Easterly ROCMuni Fund Class Action: Investor Rights Explained
• Class Action Alert: RxSight Investors Take Action Against Losses
• Investors of iRobot Corporation Urged to Act Before Deadline
• Dustin Moskovitz Expands Asana Holdings with Major Purchase
• Navigating High-Stress Careers: Insights from Executives
• Banco Comercial Português Updates on Share Buy-Back Programme Activity
• Centene Corporation Faces Class Action Over Investor Losses